Institutional investors purchased a net $468.2 thousand shares of SVRA during the quarter ended September 2017. This may signal that the smart money is gaining interest in this company as the 15.10% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
LYON STREET CAPITAL LLC Bought 305.4 Thousand shares of Savara Inc
MILLENNIUM MANAGEMENT LLC Bought 300.7 Thousand shares of Savara Inc
THE VANGUARD GROUP, INC. Bought 168.4 Thousand shares of Savara Inc